SYS Financial expands health insurance advisory service for businesses
SYS Financial, a provider of financial planning and employee benefits in Ireland, has announced the launch of its expanded private health insurance advisory service, specifically tailored to meet the needs of businesses amid soaring health insurance premiums.
This initiative comes at a critical time, as private health insurance premiums are set to increase by up to 20% this year, alongside higher government levies and reduced coverage for day-to-day medical services.
The Irish health insurance landscape is increasingly challenging for businesses, with over 400 plans on the market and frequent changes in policy terms. Identifying the most cost-effective and suitable cover for employees has become a complex task for HR and finance teams.
Ger Conalty of SYS Financial, said: "The health insurance market is notoriously complex, making it difficult to identify the most appropriate and cost-effective plans. With levies and premiums increasing, and tighter caps on routine services, many risk overpaying or being underinsured. In this environment, informed decision-making is crucial and a service like ours can make all the difference."
SYS Financials' said its new advisory service addresses these challenges by offering comprehensive plan reviews, access to exclusive plans, navigation of plan changes and risk mitigation in plan switching.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Dublin Live
28 minutes ago
- Dublin Live
Devastated Dublin mum fights for life-changing medicine to be approved for son
Our community members are treated to special offers, promotions and adverts from us and our partners. You can check out at any time. More info A desperate mother has encouraged the State to quickly approve and fund life-changing medicine for her eight-year-old son who suffers from a life-changing and life-limiting rare form of muscular dystrophy. Archie Ennis, 8, from Tallaght, suffers from Duchenne muscular dystrophy and is in desperate need of medication to help his condition. His mother, Una Ennis, said that "time is muscle" and children like Archie could face dying in their 20s if medicine is not approved quickly. Archie was diagnosed with Duchenne muscular dystrophy in December 2024. The condition affects around 120 children in Ireland. Mrs Ennis described Archie as a "little character" who loves to play with his friends and "be with all the boys". He is aware his muscles get tired but he is a "determined" boy, who is now on steroids. (Image: Una Ennis) Mrs Ennis explained: "Archie was diagnosed with Duchenne muscular dystrophy two weeks before Christmas. We had a feeling something was going on with Archie. We actually thought at the start that it was just dyspraxia. "I just thought he needed physio, but the physio wasn't helping, and she said, 'We'll go to the doctor'. [The doctor] said that Archie has Duchenne muscular dystrophy. It's a progressive muscle weakening condition which will cause his legs to become weaker and then his arms. "She said that most boys who would have Duchenne would end up in a wheelchair. To hear that and to see our perfect little boy, our whole world was just turned upside down in an instant." She went on to say that Archie's lungs will become weaker and his heart will become weaker. "Most boys in their early 20s can die from cardio myopathy, which causes the muscles in the heart to become a lot weaker," she said. (Image: Una Ennis) "As parents, you're just devastated and desperate to try and get him some help. They say it's a rare condition, but it's the most aggressive muscular dystrophy. "You hear all these stories of young boys passing away because they don't get medicine." In April, the European Medicines Agency (EMA) recommended granting conditional marketing authorisation to the drug Duvyzat, also known as Givinostat, as a treatment for Duchenne muscular dystrophy. Last week, the European Commission granted conditional market authorisation for the product. However, Mrs Ennis now fears that it could take several years for Ireland and the National Centre for Pharmacoeconomics (NCPE) to approve its use on the Irish market. She will hold a demonstration outside Leinster House on Wednesday afternoon before presenting to politicians in the AV Room from 2.30pm where she will tell them how urgent the medicine is. Mrs Ennis continued: "Every day that Archie doesn't have medicine, his muscles are dying. "If it's a year or two down the line [that the medicine is approved], I can't reverse that. I need the medicine as quick as possible, because time is muscle for Archie and all the boys with Duchenne." In addition to Givinostat, Archie will require gene therapy. A doctor in Los Angeles has said that they can give him this treatment. However, his parents have to fundraise €3.5m in order for him to travel to the US. Some €3.2m is required for the medicine, while the extra money is needed for the family to stay there for 12 weeks for the infusion. To date, over €800,000 has been raised. In the meantime, Mrs Ennis is begging the Government and the NCPE to approve Givinostat to help Archie. She is also urging Health Minister Jennifer Carroll MacNeill to attend the briefing in Leinster House on Wednesday. Fianna Fail Senator Teresa Costello has also urged the Minister to meet the affected parents. The Tallaght-based senator said she emailed the Givinostat manufacturer last week as soon as progress was made with the European approval, asking them to expedite the time the medicine would be available to Irish children. She added: "I will be watching the progress of this like a hawk because we just don't have two years to wait for this to be approved. Parents are in a really dire situation where every month there is a deterioration with their children." Join our Dublin Live breaking news service on WhatsApp. Click this link to receive your daily dose of Dublin Live content. We also treat our community members to special offers, promotions, and adverts from us and our partners. If you don't like our community, you can check out any time you like. If you're curious, you can read our Privacy Notice. For all the latest news from Dublin and surrounding areas visit our homepage.
The Journal
2 hours ago
- The Journal
Tax rebate agent appears on Revenue's list of tax defaulters
AN ONLINE TAX Rebate agent based in Co Longford has appeared on Revenue's list of tax defaulters for Q1 of 2025. The company handles overpayments of tax to Revenue for its customers and keeps 30% of any repayment Revenue issues to the customer. In its 'About Us' section on its website, Online Tax Rebate Services Limited says: 'We appreciate that many Irish tax payers do not receive their full rebates. This is due to the complexity of the process. Advertisement 'The online tax rebate process that we make available via this website is designed to make the process more accessible for Irish tax payers.' The tax rebate agent, with an address at Unit 1A, Heatherview Business Park, Athlone Road, Co Longford, reached a €188,206 settlement with Revenue made up of unpaid taxes of €101,814 and penalties of €76,360. Revenue stated that the business was subject to a Revenue investigation case due to 'non-declaration of PAYE/PRSI/USC and VAT'. According to the data from Revenue, all money owed by the company was paid in full. The biggest single tax settlement was from Lifetime Brands Europe Limited, a UK based wholesaler of household goods. The company reached a settlement amounting to €1,115,755 made up of €777,606 of unpaid taxes and €233,281 of penalties. All money owed by the company was paid in full. Readers like you are keeping these stories free for everyone... A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation. Learn More Support The Journal
Irish Post
2 hours ago
- Irish Post
Sisk begins construction work on Great Ormond Street children's cancer centre
CONSTRUCTION work has begun on a new children's cancer centre at Great Ormond Street Hospital (GOSH). Irish-headquartered John Sisk & Son (Sisk) are the main contractors for the project, which will start with four months spent demolishing the existing cancer centre. Following this excavation and works on the basement will begin, before moving 'onwards and upwards until the world-leading new centre is complete' a Sisk spokesperson confirmed. A ground-breaking event was held at the site in central London as works got underway on June 4. Ger Hayes, Sisk's Managing Director for UK South, said it marked a 'huge milestone' in the project, which has been 'six years in the making'. 'Now we transfer from the pre-contract phase into the construction phase,' he explained. The construction phase of the GOSH Children's Cancer Centre project has now begun 'We are going to really move on to the exciting bit now, which is pushing on with the demolition and the construction of the brand new state of the art cancer care centre at GOSH.' The construction phase is expected to take four years and will be undertaken while day to day life at the hospital continues. 'This is a complex build in a complex environment, working and operating within an operational hospital,' Gary Beacham, Children's Cancer Centre Delivery Director at GOSH, confirmed. Once completed the new centre will increase their cancer centre capacity by 20 per cent. It will also feature digitally advanced inpatient wards and a new hospital school. 'The thing that has got everybody behind this job is what it will be at the end,' Mr hayes explained. 'When you walk around this place and you see some of the sickest kids and families and the toll it takes on them, if we can build something that will make that better it will make it better for the clinicians it will make it better for the families, it will make it better for everybody. 'And that is the ultimate aim, that in four years' time we will be back here celebrating that.' Steven McGee, who is Sisk's Chief Operating Officer for Ireland and UK, outlined where the project is at currently. 'Weve done the soft strip, we are about to start the demotion followed by the basement box frame façade,' he said. 'So it's a four-year journey and at the end it will be a world class children's cancer care unit that will leave a lasting legacy, not just in London but in our business.' GOSH has launched the Build It. Beat It. fundraising appeal to help fund the project. At the ground-breaking event, hospital staff were joined by principal donor, John Grayken and long-time GOSH Charity supporters the Said family as well Public Health and Prevention Minister Ashley Dalton. The appeal is aiming to raise £300m to help build the Children's Cancer Centre. 'The Children's Cancer Centre will make a difference to every child who comes to GOSH, and particularly, it will help us advance how we care and treat children who have rare and complex cancers,' Mat Shaw, Great Ormond Street Hospital Chief Executive, said at the event. 'A massive thank you to everyone who is supporting the Build It. Beat It. appeal – we couldn't do this without you," he added. Mr Dalton said he hospital is a "symbol of what we can achieve when we combine the excellence of our NHS people, innovative technologies, ground-breaking treatment and world-class research". 'As someone living with cancer myself, I know how terrifying a diagnosis can be - and when it happens to our children, that's unimaginable," he added. 'These families deserve a government that's backing them every step of the way, which is why we've relaunched the Children and Young People Cancer Taskforce and will ensure children's cancer is at the forefront of our Plan for Change." GOSH and Sisk are "working hard to limit the impacts of the development on the local community and families who are coming to the hospital", they confirmed this week. Sisk are using a range of different methods for the works to limit dust, noise and vibrations during the build. See More: Children's Cancer Centre, Construction, GOSH, Sisk
